![](/remote/aHR0cHM6Ly9naWVjZG4uYmxvYi5jb3JlLndpbmRvd3MubmV0L2ZpbGV1cGxvYWRzL2ltYWdlLzIwMTgvMDMvY2FwaXRvbDIuanBn.754SSErlsmc.jpg?w=948&h=533&format=webp&mode=pad&anchor=middlecenter&scale=both&bgcolor=F0F1F2)
After a frenzied back-and-forth debate with members of Congress, President Donald Trump signed a $1.3-trillion spending bill into law today. The bill includes ongoing protections for state-legal medical marijuana business owners and patients.
Contained within this spending measure, once again, is the 2014 Rohrabacher-Blumenauer amendment, which blocks federal funds from being spent to interfere with programs or prosecute people associated with medical marijuana in states that have legalized the medicinal use of the plant.
While the U.S. government has approved several short-term spending bills in recent months, this latest bill will fund the government through September. Trump had threatened a veto, insisting that lawmakers had not adequately addressed the hundreds of thousands of DACA recipient “Dreamers” and the funding mechanism of a wall along the U.S.-Mexico border. The president relented, he said, because the federal government needed access to the bill’s increased military appropriations.
Top photo courtesy of Adobe Stock
Latest from Cannabis Business Times
- Navigating Cultivation Room Design: Optimization vs. Maximization
- Verano Opens 18th Medical Cannabis Dispensary in Pennsylvania
- Hundreds Interested in Kentucky’s Medical Cannabis Licenses; Just 17 Apply So Far
- Aurora Receives Expanded Cultivation, Unique Research Licenses for German Facility
- Curaleaf Opening 2 New York Medical Dispensaries, Launching Adult-Use Sales at 2 Other Stores
- Ohio’s Adult-Use Licensing Process Leads CBT’s Top Stories in July
- Planet 13 Launches Lifestyles Brand Company; Signs 1st Sponsored Athlete in UFC Title Contender Chito Vera
- LeafLink Acquires Leading Cannabis Banking Platform Dama Financial